Filip Fruhauf

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Ultrasonography-Guided Core Needle Biopsy in the Diagnostic Pathway of Pelvic Tumors.

Ultrasonography-Guided Core Needle Biopsy in the Diagnostic Pathway of Pelvic Tumors.

Journal: JAMA network open

Published: August 14, 2026

Pre-operative risk stratification in apparent early-stage endometrial cancer using expert ultrasound and molecular classification: a multi-center prospective observational study (PRSTEC_multipro/CEEGOG EX-07).

Pre-operative risk stratification in apparent early-stage endometrial cancer using expert ultrasound and molecular classification: a multi-center prospective observational study (PRSTEC_multipro/CEEGOG EX-07).

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: June 15, 2026

ESGO/ISUOG guidelines for needle biopsies in gynecologic oncology - the adapted version.

ESGO/ISUOG guidelines for needle biopsies in gynecologic oncology - the adapted version.

Journal: Ceska gynekologie

Published: May 11, 2026

ESGO/ISUOG guidelines for needle biopsies in gynecologic oncology - the adapted version.

ESGO/ISUOG guidelines for needle biopsies in gynecologic oncology - the adapted version.

Journal: Ceska gynekologie

Published: May 11, 2026

Mesonephric-like adenocarcinoma as an unexpected histological result after fertility saving procedure for presumed adenomyosis: a case report.

Mesonephric-like adenocarcinoma as an unexpected histological result after fertility saving procedure for presumed adenomyosis: a case report.

Journal: Frontiers in oncology

Published: March 11, 2026

High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavage.

High-grade serous ovarian cancer is associated with increased TP53 mutation burden in uterine lavage.

Journal: NPJ precision oncology

Published: January 27, 2026

Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer - PORTEC-4a an international, randomised, phase 3 trial.

Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer - PORTEC-4a an international, randomised, phase 3 trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: December 16, 2025

Prospective comparison of diagnostic accuracy of ultrasound, PET/CT and DW-MRI for preoperative assessment of pelvic lymph nodes in cervical cancer patients: results of the CANNES trial.

Prospective comparison of diagnostic accuracy of ultrasound, PET/CT and DW-MRI for preoperative assessment of pelvic lymph nodes in cervical cancer patients: results of the CANNES trial.

Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology

Published: December 13, 2025

Folate receptor alpha (FRα) expression in tubo-ovarian and endometrial tumors: a study of 923 cases.

Folate receptor alpha (FRα) expression in tubo-ovarian and endometrial tumors: a study of 923 cases.

Journal: The journal of pathology. Clinical research

Published: November 06, 2025

CTNNB1 mutation represents a recurrent driver molecular alteration in a subset of endometrial stromal tumors.

CTNNB1 mutation represents a recurrent driver molecular alteration in a subset of endometrial stromal tumors.

Journal: Virchows Archiv : an international journal of pathology

Published: October 28, 2025

A randomized, open-label phase II non-inferiority study of niraparib maintenance after 3 versus 6 cycles of platinum-based chemotherapy in patients with completely debulked advanced HRD-positive high-grade ovarian cancer in first-line therapy (N-PLUS/NOGGO-ov53/ENGOT-ov62).

A randomized, open-label phase II non-inferiority study of niraparib maintenance after 3 versus 6 cycles of platinum-based chemotherapy in patients with completely debulked advanced HRD-positive high-grade ovarian cancer in first-line therapy (N-PLUS/NOGGO-ov53/ENGOT-ov62).

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: October 14, 2025

Ultrasound-guided core needle biopsy: evaluating adequacy, accuracy, and safety in gynecologic oncology.

Ultrasound-guided core needle biopsy: evaluating adequacy, accuracy, and safety in gynecologic oncology.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: October 10, 2025

Showing 1-12 of 69

Last Updated: 09/26/2026